Joseph W. St. Geme

kSep Systems LLC provides automated single-use bioprocessing solutions to the clients in the areas of recombinant therapeutics, cell therapy and vaccines manufacturing. The company was founded by Sunil Mehta and Joseph T. McMahon in 2011 and is headquartered in Morrisville, NC.

KBI Biopharma, Inc. provides drug development and contract manufacturing services. It helps client partners accelerate and optimize drug development and manufacturing programs by offering an extensive suite of expert development and manufacturing services. The firm offers services to global pharmaceutical and biotechnology companies, and academic and non-profit organizations. The company was founded in 1996 and is headquartered in Durham, NC.

Altis Biosystems, Inc. operates as a biotechnology company. It develops patent-pending stem cell technology that recreates the human intestinal epithelium. The firm offers products such as RepliGut Planar and RepliGut Crypt. The company was founded by Michael Biron, Christopher Sims, Nancy Allbritton, Scott Magness and Yuli Wang and is headquarterd in Chapel Hill, NC.

Evren Technologies, Inc. engages in the development of wearable products treatment for PTSD and trauma-related issues. The company was founded by Blythe Karow and Weaver Gaines in 2018 and is headquartered in Newberry, FL.

Part of Fortrea Holdings, Inc., Labcorp Early Development Laboratories Ltd. is a British company that provides early-stage and late-stage product development services. The company is based in Harrogate, UK. Labcorp Early Development Laboratories was founded in 1974.

DynPort Vaccine Co. LLC develops vaccines, biologic products and small molecule anti-infectives. It provides its products and services to the defense and military sectors in the United States. The company was founded in 1997 by Zsolt Pál Harsányi and is headquartered in Reston, VA.

BioStratum, Inc. develops and distributes pharmaceutical products. Its products are used for treatment of diabetes and diabetic complications. The firm also develops anti-tumor, cancer, diabetic kidney disease and diabetic eye disease drugs. The company was founded by Karl Tryggvason and J. Wesley Fox in 1994 and is headquartered in Durham, NC.

Viamet Pharmaceuticals, Inc. discovers and develops inhibitors of validated metalloenzymes. The firm's clinical portfolio includes novel agents to treat both chronic and life threatening fungal infections. It also leverage our metalloenzyme expertise in other therapeutic areas including oncology and orphan diseases. The company was founded by Thomas V. O’Halloran and Holden H. Thorp on August 18, 2005 and is headquartered in Durham, NC.

Propella Therapeutics, Inc. is an American biopharmaceutical company that has developed a platform combining medicinal chemistry with lymphatic targeting to create best- or first-in-class oncology drugs that have validated MOAs and biological targets but suffer from efficacy and safety limitations. Propella is based in an undisclosed location and is dedicated to meeting the needs of cancer patients currently underserved by existing standards of care. The company is currently in the phase 1 portion of a phase 1/2a study of its lead product candidate, PRL-02, for the treatment of metastatic prostate cancer. The company was founded by William E. Peterson, Charles Birbara, Milt V. Peterson, and the CEO is William Moore.

Innocrin Pharmaceuticals Holdings LLC discovers and develops oral inhibitors for the treatment of Castration-Resistant Prostate Cancer (CRPC). The company is headquartered in Durham, NC.

Innocrin Pharmaceuticals, Inc. develops oral inhibitors for the treatment of castration-resistant prostate cancer. It develops small molecule CYP17 lyase-selective inhibitors to treat resistant hormonally-dependent breast and prostate cancers. The firm’s product under pipeline is VT-464, a dual mechanism lyase-selective CYP17 inhibitor and androgen receptor (AR) antagonist that disrupts the validated biochemical pathways required for prostate cancer growth androgen biosynthesis and AR transcriptional signaling. The company was founded in 2004 and is headquartered in Durham, NC.

Viamet Pharmaceuticals Corp. engages in the discovery, development, and commercialization of novel pharmaceuticals based on its proprietary metalloenzyme chemistry and biology technology platform. Its clinical portfolio includes novel agents to treat chronic and life threatening fungal infections. Its products include VT-1161, an oral agent that treats onychomycosis; VT-1129, which treats cryptococcal meningitis; and VT-1598, that treats coccidioidomycosis. The company was founded by Herbert Holden Thorp and Thomas V. O'Halloran in December 2011 and is headquartered in Durham, NC.

Case Western Reserve University provides educational services. It offers a variety of undergraduate degree courses and graduate and professional options such as arts and sciences, dentistry, engineering, law, management, medicine, nursing, social work, and more. The firm also offers dual-degree programs. The company was founded in 1826 and is headquartered in Cleveland, OH.

Global Factory, Inc. provides collaborative manufacturing execution systems. The firm's software gather, organize & analyze demand, production & quality data from various sources and monitor key indicators & execute business processes to control, manage & optimize distributed manufacturing operations. The company was founded in 1999 and is headquartered in Santa Clara, CA.